510(k) K201938
K201938 is an FDA 510(k) premarket notification submitted by Lin-Zhi International, Inc. for the device "LZI Fentanyl II Enzyme Immunoassay". The FDA issued a decision of Substantially Equivalent on Aug 7, 2020. The device falls under product code DJG (Enzyme Immunoassay, Opiates), a Class II device regulated under 21 CFR 862.3650. Lin-Zhi International, Inc. has 49 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 7, 2020
- Date Received
- Jul 13, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Opiates
- Device Class
- Class II
- Regulation Number
- 862.3650
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Lin-Zhi International, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.